EnteroMedics to Present at the 28th Annual J.P. Morgan Healthcare Conference

ST. PAUL, Minn.--(BUSINESS WIRE)--EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that Mark B. Knudson, Ph.D., Chief Executive Officer, is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 14th at 8:30 a.m. Pacific Time. Dr. Knudson will provide an overview of the Company and an update on its VBLOC® vagal blocking therapy development program.